- Home
- FFIC vs TSHA Comparison
FFIC vs TSHA Comparison
Compare FFIC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- TSHA
- Stock Information
- Founded
- FFIC 1929
- TSHA 2019
- Country
- FFIC United States
- TSHA United States
- Employees
- FFIC N/A
- TSHA N/A
- Industry
- FFIC Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- FFIC Finance
- TSHA Health Care
- Exchange
- FFIC Nasdaq
- TSHA Nasdaq
- Market Cap
- FFIC 454.6M
- TSHA 403.7M
- IPO Year
- FFIC 1995
- TSHA 2020
- Fundamental
- Price
- FFIC $14.26
- TSHA $1.85
- Analyst Decision
- FFIC Hold
- TSHA Strong Buy
- Analyst Count
- FFIC 4
- TSHA 8
- Target Price
- FFIC $15.50
- TSHA $6.63
- AVG Volume (30 Days)
- FFIC 453.4K
- TSHA 4.9M
- Earning Date
- FFIC 01-23-2025
- TSHA 11-13-2024
- Dividend Yield
- FFIC 6.17%
- TSHA N/A
- EPS Growth
- FFIC N/A
- TSHA N/A
- EPS
- FFIC 0.87
- TSHA N/A
- Revenue
- FFIC $193,714,000.00
- TSHA $9,915,000.00
- Revenue This Year
- FFIC N/A
- TSHA N/A
- Revenue Next Year
- FFIC $14.16
- TSHA N/A
- P/E Ratio
- FFIC $16.39
- TSHA N/A
- Revenue Growth
- FFIC 4.54
- TSHA N/A
- 52 Week Low
- FFIC $10.74
- TSHA $1.19
- 52 Week High
- FFIC $18.59
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- FFIC 27.93
- TSHA 38.54
- Support Level
- FFIC $13.97
- TSHA $1.80
- Resistance Level
- FFIC $15.45
- TSHA $2.72
- Average True Range (ATR)
- FFIC 0.59
- TSHA 0.23
- MACD
- FFIC -0.42
- TSHA -0.10
- Stochastic Oscillator
- FFIC 7.30
- TSHA 3.81
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.